Notifytherapeutics
Founded 2021 · 9 employees on LinkedIn · 1 known investors
Notify Therapeutics is developing a non-hormonal female fertility treatment that targets the hormone-independent phase of early ovarian follicle development, aimed at infertile women who do not respond to standard hormone therapy. The company has shown proof-of-concept efficacy in rodent models and ex-vivo patient samples, with preliminary toxicology studies indicating no safety concerns.
Investors · 1
Frequently asked questions
- What does Notifytherapeutics do?
- Notify Therapeutics is developing a non-hormonal female fertility treatment that targets the hormone-independent phase of early ovarian follicle development, aimed at infertile women who do not respond to standard hormone therapy. The company has shown proof-of-concept efficacy in rodent models and ex-vivo patient samples, with preliminary toxicology studies indicating no safety concerns.
- Who are Notifytherapeutics's investors?
- Notifytherapeutics's investors include +ND Capital.